RT Article
T1 Ethics, pricing and the pharmaceutical industry
JF Journal of business ethics
VO 11
IS 8
SP 617
OP 626
A1 Spinello, Richard A.
LA English
PB Springer Science + Business Media B. V
YR 1992
UL https://www.ixtheo.de/Record/1785603256
AB This paper explores the ethical obligations of pharmaceutical companies to charge fair prices for essential medicines. The moral issue at stake here is distributive justice. Rawls' framework is especially germane since it underlines the material benefits everyone deserves as Kantian persons and the need for an egalitarian approach for the distribution of society's essential commodities such as health care. This concern for distributive justice should be a critical factor in the equation of variables used to set prices for pharmaceuticals.
K1 Pharmaceutical Company
K1 Pharmaceutical Industry
K1 Critical Factor
K1 Economic Growth
K1 Health Care
DO 10.1007/BF00872273